Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal


Classification: B

Drug products: Abelonelle 28, Anastrella 28, Erlibelle, Frivelle, Jadelle, Jadelle®, Jaydess, Kyleena, Leverette, Leverette 21, Levesia, Levodonna, Levonorgestrel ABECE, Levonorgestrel Apofri, Levonorgestrel/Etinylestradiol Ebb, Levosert, Loette 28, Mirena, Neovletta®, Neovletta® 28, NorLevo, Novogyn, Postinor, Prionelle, Prionelle 28, Rigevidon, Rigevidoncont, Trinordiol, Trinordiol® 28, Trionetta®, Trionetta® 28, Triregol

ATC code: G02BA03, G03AA07, G03AB03, G03AC03, G03AD01

Substances: levonorgestrel


As the substance is only used by women, analyses on sex or gender differences have not been considered relevant.

Additional information

The approved indications for levonorgestrel in combination with ethinylestradiol are contraception, emergency contraception and abortifacient [1-3].

Updated: 2017-02-09

Date of litterature search: 2016-12-20


  1. Fass.se [cited 2016-12-20]. länk
  2. Physicians' Desk Reference. http://www.pdr.net. [cited 2016-12-20]. länk
  3. Dollery C Sir, editor. Therapeutic drugs. 2nd ed. Edinburgh: Churchill Livingstone; 1999
  4. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.] Socialstyrelsens statistikdatabas

Authors: Mia von Euler, Linnéa Karlsson Lind

Reviewed by: Mia von Euler

Approved by: Karin Schenck-Gustafsson